Title : Calcitonin gene-related peptide mediates the cardioprotective effects of rutaecarpine against ischaemia-reperfusion injury in spontaneously hypertensive rats.

Pub. Date : 2009 Jul

PMID : 19076981






9 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Calcitonin gene-related peptide mediates the cardioprotective effects of rutaecarpine against ischaemia-reperfusion injury in spontaneously hypertensive rats. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
2 It has been shown that calcitonin gene-related peptide (CGRP) plays an important role in mediating the cardioprotection exerted by rutaecarpine in normal animals. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
3 It has been shown that calcitonin gene-related peptide (CGRP) plays an important role in mediating the cardioprotection exerted by rutaecarpine in normal animals. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
4 The aim of the present study was to determine whether rutaecarpine is able to decrease the susceptibility of hypertensive animals to ischaemia-reperfusion injury by stimulating CGRP release. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
5 The effect of 10 or 30 micromol/L rutaecarpine on CGRP release was also examined in isolated aortic rings set up in a homeothermal organ bath. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
6 Rutaecarpine treatment resulted in a hypotensive effect in SHR concomitant with increases in plasma CGRP levels. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
7 In addition, rutaecarpine significantly stimulated the release of CGRP from aortic rings. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
8 The results of the present study suggest that the increased cardiac susceptibility to ischaemia-reperfusion injury in SHR is related to decreased plasma CGRP levels and that antihypertensive therapy with rutaecarpine reverses cardiac susceptibility to reperfusion injury by stimulating CGRP release. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus
9 The results of the present study suggest that the increased cardiac susceptibility to ischaemia-reperfusion injury in SHR is related to decreased plasma CGRP levels and that antihypertensive therapy with rutaecarpine reverses cardiac susceptibility to reperfusion injury by stimulating CGRP release. rutecarpine calcitonin-related polypeptide alpha Rattus norvegicus